Evidence map›Paper›PMID 42212241›Full record

ArticleJournal of structural biology: X2026

Structural insights into interdomain interactions in

Ryo Hatanaka, Yukiko Ohsumi, Hiroki Matsui, Ayuna Inoguchi, Hina Yuasa, Fumika Mi-Ichi, Jun-Ichi Kishikawa, Tomoo Shiba

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of structural biology: X, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ryo HatanakaDepartment of Applied Biology, Graduate School of Science and Technology, Kyoto Institute of Technology, Matsugasaki-hashikami-cho, Sakyo-ku, Kyoto 606-8585, Japan.
Yukiko OhsumiDepartment of Applied Biology, Graduate School of Science and Technology, Kyoto Institute of Technology, Matsugasaki-hashikami-cho, Sakyo-ku, Kyoto 606-8585, Japan.
Hiroki MatsuiDepartment of Applied Biology, Graduate School of Science and Technology, Kyoto Institute of Technology, Matsugasaki-hashikami-cho, Sakyo-ku, Kyoto 606-8585, Japan.
Ayuna InoguchiUndergraduate Program of Applied Biology, School of Science and Technology, Kyoto Institute of Technology, Matsugasaki-hashikami-cho, Sakyo-ku, Kyoto 606-8585, Japan.
Hina YuasaDepartment of Applied Biology, Graduate School of Science and Technology, Kyoto Institute of Technology, Matsugasaki-hashikami-cho, Sakyo-ku, Kyoto 606-8585, Japan.
Fumika Mi-IchiCentral Laboratory, Institute of Tropical Medicine (NEKKEN), Nagasaki University, 1-12-4, Sakamoto, Nagasaki 852-8523, Japan.
Jun-Ichi KishikawaFaculty of Applied Biology, Kyoto Institute of Technology, Matsugasaki-hashikami-cho, Sakyo-ku, Kyoto 606-8585, Japan.
Tomoo ShibaFaculty of Applied Biology, Kyoto Institute of Technology, Matsugasaki-hashikami-cho, Sakyo-ku, Kyoto 606-8585, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The biosynthetic pathway of 3'-phosphoadenosine-5'-phosphosulfate (PAPS) is a universal and essential metabolic process in many organisms, providing the activated sulfate donor required for the synthesis of diverse sulfated metabolites. However, this pathway has undergone substantial evolutionary diversification among species. In

Indexed as

Adenosine5′phosphosulfatekinaseAmoebiasisEntamoeba histolyticaSingle particle cryo-EMSulfate activationX-ray crystallography

Identifiers

PMID42212241
PMCPMC13213808

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.